Search research articles
Contact Us
Filters
Showing results (1031-1040 of 1,064) with videos related to
Page
of 107
Sort By:
Bioscience Reports
|
December 9, 2017
<i>MiR-29a</i>: a potential therapeutic target and promising biomarker in tumors
Jin-Yan Wang, Qian Zhang, Dan-Dan Wang, et al.
Environmental Microbiology
|
December 1, 2016
The chimeric nature of the genomes of marine magnetotactic coccoid-ovoid bacteria defines a novel group of Proteobacteria
Boyang Ji, Sheng-Da Zhang, Wei-Jia Zhang, et al.
Frontiers in Oncology
|
July 12, 2021
Role of NRP1 in Bladder Cancer Pathogenesis and Progression
Yang Dong, Wei-Ming Ma, Zhen-Duo Shi, et al.
Journal of Hepatology
|
August 2, 2020
p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma
Yuan-Deng Luo, Lei Fang, Hong-Qiang Yu, et al.
Journal of Applied Clinical Medical Physics
|
May 11, 2023
A combined radiomic model distinguishing GISTs from leiomyomas and schwannomas in the stomach based on endoscopic ultrasonography images
Xian-Da Zhang, Ling Zhang, Ting-Ting Gong, et al.
Environmental Science & Technology
|
December 12, 2025
Different Carbon Neutrality Strategies Induce Substantially Divergent Health Benefits and Distributional Impacts in China
Da Gao, Chenfei Qu, Bin Zhao, et al.
Global Change Biology
|
October 13, 2025
Demystifying the Romanticized Narratives About Carbon Credits From Voluntary Forest Conservation
Thales A P West, Kelsey Alford-Jones, Philippe Delacote, et al.
Nature Methods
|
November 27, 2025
FX-Cell: a method for single-cell RNA sequencing on difficult-to-digest and cryopreserved plant samples
Xin Ming, Mu-Chun Wan, Zheng-Da Zhang, et al.
American Journal of Hypertension
|
February 4, 2025
Integrated Transcriptomic and Metabolomic Analysis of Rat PASMCs Reveals the Underlying Mechanism for Pulmonary Arterial Hypertension
Jie Hou, Ke Liu, Meng-Jie Zhang, et al.
British Journal of Cancer
|
September 1, 2017
Phase 1 safety, pharmacokinetic and pharmacodynamic study of the cyclin-dependent kinase inhibitor dinaciclib administered every three weeks in patients with advanced malignancies
Monica M Mita, Alain C Mita, Jennifer L Moseley, et al.
Page
of 107
Search research articles
Search
Showing results (1031-1040 of 1,064) with videos related to
Sort By:
Page
of 107
Bioscience Reports
|
December 9, 2017
<i>MiR-29a</i>: a potential therapeutic target and promising biomarker in tumors
Jin-Yan Wang, Qian Zhang, Dan-Dan Wang, et al.
Environmental Microbiology
|
December 1, 2016
The chimeric nature of the genomes of marine magnetotactic coccoid-ovoid bacteria defines a novel group of Proteobacteria
Boyang Ji, Sheng-Da Zhang, Wei-Jia Zhang, et al.
Frontiers in Oncology
|
July 12, 2021
Role of NRP1 in Bladder Cancer Pathogenesis and Progression
Yang Dong, Wei-Ming Ma, Zhen-Duo Shi, et al.
Journal of Hepatology
|
August 2, 2020
p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma
Yuan-Deng Luo, Lei Fang, Hong-Qiang Yu, et al.
Journal of Applied Clinical Medical Physics
|
May 11, 2023
A combined radiomic model distinguishing GISTs from leiomyomas and schwannomas in the stomach based on endoscopic ultrasonography images
Xian-Da Zhang, Ling Zhang, Ting-Ting Gong, et al.
Environmental Science & Technology
|
December 12, 2025
Different Carbon Neutrality Strategies Induce Substantially Divergent Health Benefits and Distributional Impacts in China
Da Gao, Chenfei Qu, Bin Zhao, et al.
Global Change Biology
|
October 13, 2025
Demystifying the Romanticized Narratives About Carbon Credits From Voluntary Forest Conservation
Thales A P West, Kelsey Alford-Jones, Philippe Delacote, et al.
Nature Methods
|
November 27, 2025
FX-Cell: a method for single-cell RNA sequencing on difficult-to-digest and cryopreserved plant samples
Xin Ming, Mu-Chun Wan, Zheng-Da Zhang, et al.
American Journal of Hypertension
|
February 4, 2025
Integrated Transcriptomic and Metabolomic Analysis of Rat PASMCs Reveals the Underlying Mechanism for Pulmonary Arterial Hypertension
Jie Hou, Ke Liu, Meng-Jie Zhang, et al.
British Journal of Cancer
|
September 1, 2017
Phase 1 safety, pharmacokinetic and pharmacodynamic study of the cyclin-dependent kinase inhibitor dinaciclib administered every three weeks in patients with advanced malignancies
Monica M Mita, Alain C Mita, Jennifer L Moseley, et al.
Page
of 107